The US Food and Drug Administration (FDA) is offering a detailed look at how real-world evidence sources – from registries to claims data – can be used to support marketing applications for medical ...

Despite $2.5 million placeholder price tags, the Institute for Clinical and Economic Review draft evidence report considers gene therapy cost-effective versus comparators in both hemophilia A and B.

To review the five NASA evidence reports, the National Academies assembled an 11-member committee with expertise in aerospace medicine, occupational health, clinical care, human performance and human ...